HomeInsightsStock Comparison

Sun Pharma Advanced Research Company Ltd vs Venus Remedies Ltd Stock Comparison

Sun Pharma Advanced Research Company Ltd vs Venus Remedies Ltd Stock Comparison

Last Updated on: Jun 03, 2025

Key Highlights

  • The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 195.6 as of 03 Jun 15:30.
  • The P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Venus Remedies Ltd changed from 5.5 on March 2021 to 15.3 on March 2024 . This represents a CAGR of 29.15% over 4 years.
  • The Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 12005 crore on March 2024 . This represents a CAGR of 43.58% over 2 yearsThe Market Cap of Venus Remedies Ltd changed from ₹ 27.77 crore on March 2020 to ₹ 436.3 crore on March 2024 . This represents a CAGR of 73.48% over 5 years.
  • The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ 27.19 crore as compare to the Dec '24 revenue of ₹ 15.1 crore. This represent the growth of 80.07% The revenue of Venus Remedies Ltd for the Mar '25 is ₹ 201.73 crore as compare to the Dec '24 revenue of ₹ 188.8 crore. This represent the growth of 6.85%.
  • The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ -53.18 crore as compare to the Dec '24 ebitda of ₹ -73.5 crore. This represent the decline of -27.65% The ebitda of Venus Remedies Ltd for the Mar '25 is ₹ 35.76 crore as compare to the Dec '24 ebitda of ₹ 30.3 crore. This represent the growth of 18.02%.
  • The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -59.77 crore over 8 quarters. This represents a CAGR of -20.83% The net profit of Venus Remedies Ltd changed from ₹ 1.18 crore to ₹ 21 crore over 8 quarters. This represents a CAGR of 321.86% .
  • The Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Venus Remedies Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking was transferred and vested into the Company with effect from February 28, 2007.

About Venus Remedies Ltd

  • Incorporated in 1989 Venus Remedies Ltd (formerly known Venus Glucose Pvt Ltd), was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited.
  • The Company was promoted and managed by Chaudhary & Family.
  • The Company is one of the handful player in pharmaceutical sector to launch injectables globally.
  • It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India).
  • In priority, the Company was mainly engaged in I/V Fluids & Injectables, Ceftazidime, Amlodipine, Gliclazide, Lisinopril, etc. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana.

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company to table results

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

13 May 2025 15:59

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Kalpataru Projects International Ltd, Inox Wind Ltd, Data Patterns (India) Ltd, Triveni Tu...

Read more

07 Mar 2025 14:30

News

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

01 Feb 2025 10:56

News

Sun Pharma Advanced Research Company to acquire 55% stake in Tiller Therapeutics

Sun Pharma Advanced Research Company announced the signing of a binding Letter of Intent (...

Read more

17 Dec 2024 09:34

Venus Remedies Ltd News Hub

News

Venus Remedies spurts after Q4 PAT climbs 100% YoY to Rs 21 cr

However, revenue from operations decreased marginally to Rs 194.97 crore in Q4 FY25, as ag...

Read more

27 May 2025 11:37

News

Venus Remedies to hold board meeting

Venus Remedies will hold a meeting of the Board of Directors of the Company on 26 May 2025...

Read more

17 May 2025 16:57

News

Venus Remedies jumps as investigational drug secures QIDP tag from USFDA

The drug is intended for the treatment of bloodstream infections caused by polymyxin B (PM...

Read more

17 Apr 2025 10:23

News

Venus Remedies gains on strategic MET-X partnership

MET-X, a metallo-beta-lactamase (MBL) inhibitor, targets drug-resistant Gram-negative bact...

Read more

25 Feb 2025 11:26

News

Venus Remedies hits the roof after Q3 PAT soars to Rs 20 cr

Profit before exceptional items and tax in Q3 FY25 was at Rs 14.97 crore, up 92.42% from R...

Read more

05 Feb 2025 10:35

News

Venus Remedies Ltd leads gainers in 'B' group

Stallion India Fluorochemicals Ltd, Bliss GVS Pharma Ltd, BEML Land Assets Ltd and Repro I...

Read more

05 Feb 2025 12:15

SWOT Analysis Of Venus Remedies Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Venus Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd

Which company has a larger market capitalization, Sun Pharma Advanced Research Company Ltd or Venus Remedies Ltd?

Market cap of Sun Pharma Advanced Research Company Ltd is 6,347 Cr while Market cap of Venus Remedies Ltd is 614 Cr

What are the key factors driving the stock performance of Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd?

The stock performance of Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd?

As of June 3, 2025, the Sun Pharma Advanced Research Company Ltd stock price is INR ₹195.6. On the other hand, Venus Remedies Ltd stock price is INR ₹459.8.

How do dividend payouts of Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd compare?

To compare the dividend payouts of Sun Pharma Advanced Research Company Ltd and Venus Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions